Indo US Bio-Tech Limited (BSE: INDOUS.BO) Stock Competitors & Peer Comparison
See INDOUS.BO's competitors and their performance on the BSE and across the wider stock market.
Peer Comparison Table: Agricultural Inputs Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for INDOUS.BO and its BSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| INDOUS.BO | ₹81.36 | -2.40% | 1.7B | 12.79 | ₹6.54 | N/A |
| FACT.BO | ₹866.15 | +10.42% | 567B | -1442.07 | -₹0.61 | +0.04% |
| FACT.NS | ₹866.25 | +10.46% | 566.9B | -1441.90 | -₹0.61 | +0.04% |
| COROMANDEL.BO | ₹1,948.85 | +1.25% | 563.6B | 28.85 | ₹66.35 | +0.57% |
| COROMANDEL.NS | ₹1,949.70 | +1.20% | 563.5B | 30.77 | ₹62.20 | +0.57% |
| UPL.NS | ₹589.30 | +3.04% | 493.8B | 25.24 | ₹23.18 | +1.03% |
| UPL.BO | ₹587.00 | +2.80% | 491.4B | 25.19 | ₹23.18 | +1.03% |
| PIIND.NS | ₹2,508.30 | +1.35% | 380.5B | 32.94 | ₹76.14 | +0.40% |
| PIIND.BO | ₹2,509.85 | +1.49% | 373.6B | 32.51 | ₹76.28 | +0.40% |
| SUMICHEM.BO | ₹530.60 | +1.33% | 262.4B | 43.99 | ₹11.85 | +0.25% |
Stock Comparison
The Fertilisers And Chemicals Travancore Limited (BSE: FACT.BO)
INDOUS.BO vs FACT.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, FACT.BO has a market cap of 567B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while FACT.BO trades at ₹866.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas FACT.BO's P/E ratio is -1442.07. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to FACT.BO's ROE of -0.08%. Regarding short-term risk, INDOUS.BO is less volatile compared to FACT.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check FACT.BO's competition here
The Fertilisers And Chemicals Travancore Limited (NSE: FACT.NS)
INDOUS.BO vs FACT.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, FACT.NS has a market cap of 566.9B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while FACT.NS trades at ₹866.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas FACT.NS's P/E ratio is -1441.90. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to FACT.NS's ROE of -0.08%. Regarding short-term risk, INDOUS.BO is less volatile compared to FACT.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check FACT.NS's competition here
Coromandel International Limited (BSE: COROMANDEL.BO)
INDOUS.BO vs COROMANDEL.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, COROMANDEL.BO has a market cap of 563.6B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while COROMANDEL.BO trades at ₹1,948.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas COROMANDEL.BO's P/E ratio is 28.85. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to COROMANDEL.BO's ROE of +0.14%. Regarding short-term risk, INDOUS.BO is less volatile compared to COROMANDEL.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check COROMANDEL.BO's competition here
Coromandel International Limited (NSE: COROMANDEL.NS)
INDOUS.BO vs COROMANDEL.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, COROMANDEL.NS has a market cap of 563.5B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while COROMANDEL.NS trades at ₹1,949.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas COROMANDEL.NS's P/E ratio is 30.77. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to COROMANDEL.NS's ROE of +0.14%. Regarding short-term risk, INDOUS.BO is less volatile compared to COROMANDEL.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check COROMANDEL.NS's competition here
UPL Limited (NSE: UPL.NS)
INDOUS.BO vs UPL.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, UPL.NS has a market cap of 493.8B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while UPL.NS trades at ₹589.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas UPL.NS's P/E ratio is 25.24. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to UPL.NS's ROE of +0.06%. Regarding short-term risk, INDOUS.BO is more volatile compared to UPL.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check UPL.NS's competition here
UPL Limited (BSE: UPL.BO)
INDOUS.BO vs UPL.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, UPL.BO has a market cap of 491.4B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while UPL.BO trades at ₹587.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas UPL.BO's P/E ratio is 25.19. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to UPL.BO's ROE of +0.06%. Regarding short-term risk, INDOUS.BO is more volatile compared to UPL.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check UPL.BO's competition here
PI Industries Limited (NSE: PIIND.NS)
INDOUS.BO vs PIIND.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, PIIND.NS has a market cap of 380.5B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while PIIND.NS trades at ₹2,508.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas PIIND.NS's P/E ratio is 32.94. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to PIIND.NS's ROE of +0.10%. Regarding short-term risk, INDOUS.BO is more volatile compared to PIIND.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check PIIND.NS's competition here
PI Industries Limited (BSE: PIIND.BO)
INDOUS.BO vs PIIND.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, PIIND.BO has a market cap of 373.6B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while PIIND.BO trades at ₹2,509.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas PIIND.BO's P/E ratio is 32.51. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to PIIND.BO's ROE of +0.10%. Regarding short-term risk, INDOUS.BO is more volatile compared to PIIND.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check PIIND.BO's competition here
Sumitomo Chemical India Limited (BSE: SUMICHEM.BO)
INDOUS.BO vs SUMICHEM.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, SUMICHEM.BO has a market cap of 262.4B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while SUMICHEM.BO trades at ₹530.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas SUMICHEM.BO's P/E ratio is 43.99. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to SUMICHEM.BO's ROE of +0.18%. Regarding short-term risk, INDOUS.BO is more volatile compared to SUMICHEM.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check SUMICHEM.BO's competition here
Sumitomo Chemical India Limited (NSE: SUMICHEM.NS)
INDOUS.BO vs SUMICHEM.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, SUMICHEM.NS has a market cap of 260.3B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while SUMICHEM.NS trades at ₹530.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas SUMICHEM.NS's P/E ratio is 43.90. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to SUMICHEM.NS's ROE of +0.18%. Regarding short-term risk, INDOUS.BO is more volatile compared to SUMICHEM.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check SUMICHEM.NS's competition here
Bayer CropScience Limited (NSE: BAYERCROP.NS)
INDOUS.BO vs BAYERCROP.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, BAYERCROP.NS has a market cap of 183.8B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while BAYERCROP.NS trades at ₹4,089.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas BAYERCROP.NS's P/E ratio is 25.10. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to BAYERCROP.NS's ROE of +0.24%. Regarding short-term risk, INDOUS.BO is more volatile compared to BAYERCROP.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check BAYERCROP.NS's competition here
Bayer CropScience Limited (BSE: BAYERCROP.BO)
INDOUS.BO vs BAYERCROP.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, BAYERCROP.BO has a market cap of 183.7B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while BAYERCROP.BO trades at ₹4,089.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas BAYERCROP.BO's P/E ratio is 25.08. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to BAYERCROP.BO's ROE of +0.24%. Regarding short-term risk, INDOUS.BO is more volatile compared to BAYERCROP.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check BAYERCROP.BO's competition here
Atul Ltd (BSE: ATUL7.BO)
INDOUS.BO vs ATUL7.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, ATUL7.BO has a market cap of 179B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while ATUL7.BO trades at ₹7,100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas ATUL7.BO's P/E ratio is N/A. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to ATUL7.BO's ROE of +0.13%. Regarding short-term risk, INDOUS.BO is more volatile compared to ATUL7.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check ATUL7.BO's competition here
Chambal Fertilisers and Chemicals Limited (NSE: CHAMBLFERT.NS)
INDOUS.BO vs CHAMBLFERT.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, CHAMBLFERT.NS has a market cap of 171.5B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while CHAMBLFERT.NS trades at ₹427.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas CHAMBLFERT.NS's P/E ratio is 8.79. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to CHAMBLFERT.NS's ROE of +0.20%. Regarding short-term risk, INDOUS.BO is more volatile compared to CHAMBLFERT.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check CHAMBLFERT.NS's competition here
Chambal Fertilisers and Chemicals Limited (BSE: CHAMBLFERT.BO)
INDOUS.BO vs CHAMBLFERT.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, CHAMBLFERT.BO has a market cap of 170.9B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while CHAMBLFERT.BO trades at ₹427.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas CHAMBLFERT.BO's P/E ratio is 8.77. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to CHAMBLFERT.BO's ROE of +0.20%. Regarding short-term risk, INDOUS.BO is more volatile compared to CHAMBLFERT.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check CHAMBLFERT.BO's competition here
E.I.D.- Parry (India) Limited (NSE: EIDPARRY.NS)
INDOUS.BO vs EIDPARRY.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, EIDPARRY.NS has a market cap of 144.2B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while EIDPARRY.NS trades at ₹796.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas EIDPARRY.NS's P/E ratio is -82.36. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to EIDPARRY.NS's ROE of +0.04%. Regarding short-term risk, INDOUS.BO is less volatile compared to EIDPARRY.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check EIDPARRY.NS's competition here
E.I.D.- Parry (India) Limited (BSE: EIDPARRY.BO)
INDOUS.BO vs EIDPARRY.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, EIDPARRY.BO has a market cap of 144B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while EIDPARRY.BO trades at ₹796.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas EIDPARRY.BO's P/E ratio is 40.76. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to EIDPARRY.BO's ROE of +0.04%. Regarding short-term risk, INDOUS.BO is less volatile compared to EIDPARRY.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check EIDPARRY.BO's competition here
Paradeep Phosphates Limited (NSE: PARADEEP.NS)
INDOUS.BO vs PARADEEP.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, PARADEEP.NS has a market cap of 130.4B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while PARADEEP.NS trades at ₹163.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas PARADEEP.NS's P/E ratio is 13.94. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to PARADEEP.NS's ROE of +0.16%. Regarding short-term risk, INDOUS.BO is less volatile compared to PARADEEP.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check PARADEEP.NS's competition here
Paradeep Phosphates Limited (BSE: PARADEEP.BO)
INDOUS.BO vs PARADEEP.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, PARADEEP.BO has a market cap of 130.3B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while PARADEEP.BO trades at ₹163.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas PARADEEP.BO's P/E ratio is 13.45. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to PARADEEP.BO's ROE of +0.16%. Regarding short-term risk, INDOUS.BO is less volatile compared to PARADEEP.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check PARADEEP.BO's competition here
Madhya Bharat Agro Products Limited (NSE: MBAPL.NS)
INDOUS.BO vs MBAPL.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, MBAPL.NS has a market cap of 73.8B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while MBAPL.NS trades at ₹167.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas MBAPL.NS's P/E ratio is 49.23. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to MBAPL.NS's ROE of +0.31%. Regarding short-term risk, INDOUS.BO is less volatile compared to MBAPL.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check MBAPL.NS's competition here
Sharda Cropchem Limited (BSE: SHARDACROP.BO)
INDOUS.BO vs SHARDACROP.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, SHARDACROP.BO has a market cap of 69.2B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while SHARDACROP.BO trades at ₹795.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas SHARDACROP.BO's P/E ratio is 11.06. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to SHARDACROP.BO's ROE of +0.22%. Regarding short-term risk, INDOUS.BO is less volatile compared to SHARDACROP.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check SHARDACROP.BO's competition here
Sharda Cropchem Limited (NSE: SHARDACROP.NS)
INDOUS.BO vs SHARDACROP.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, SHARDACROP.NS has a market cap of 69.2B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while SHARDACROP.NS trades at ₹795.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas SHARDACROP.NS's P/E ratio is 11.06. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to SHARDACROP.NS's ROE of +0.22%. Regarding short-term risk, INDOUS.BO is less volatile compared to SHARDACROP.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check SHARDACROP.NS's competition here
Rashtriya Chemicals and Fertilizers Limited (NSE: RCF.NS)
INDOUS.BO vs RCF.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, RCF.NS has a market cap of 68.7B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while RCF.NS trades at ₹122.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas RCF.NS's P/E ratio is 15.42. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to RCF.NS's ROE of +0.09%. Regarding short-term risk, INDOUS.BO is more volatile compared to RCF.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check RCF.NS's competition here
Rashtriya Chemicals and Fertilizers Limited (BSE: RCF.BO)
INDOUS.BO vs RCF.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, RCF.BO has a market cap of 68.6B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while RCF.BO trades at ₹122.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas RCF.BO's P/E ratio is 16.05. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to RCF.BO's ROE of +0.09%. Regarding short-term risk, INDOUS.BO is more volatile compared to RCF.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check RCF.BO's competition here
Gujarat State Fertilizers & Chemicals Limited (NSE: GSFC.NS)
INDOUS.BO vs GSFC.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, GSFC.NS has a market cap of 63.4B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while GSFC.NS trades at ₹160.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas GSFC.NS's P/E ratio is 9.49. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to GSFC.NS's ROE of +0.06%. Regarding short-term risk, INDOUS.BO is more volatile compared to GSFC.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check GSFC.NS's competition here
Gujarat State Fertilizers & Chemicals Limited (BSE: GSFC.BO)
INDOUS.BO vs GSFC.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, GSFC.BO has a market cap of 63.4B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while GSFC.BO trades at ₹160.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas GSFC.BO's P/E ratio is 9.47. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to GSFC.BO's ROE of +0.06%. Regarding short-term risk, INDOUS.BO is more volatile compared to GSFC.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check GSFC.BO's competition here
Krishana Phoschem Limited (NSE: KRISHANA.NS)
INDOUS.BO vs KRISHANA.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, KRISHANA.NS has a market cap of 62.1B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while KRISHANA.NS trades at ₹205.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas KRISHANA.NS's P/E ratio is 34.48. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to KRISHANA.NS's ROE of +0.39%. Regarding short-term risk, INDOUS.BO is less volatile compared to KRISHANA.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check KRISHANA.NS's competition here
Dhanuka Agritech Limited (BSE: DHANUKA.BO)
INDOUS.BO vs DHANUKA.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, DHANUKA.BO has a market cap of 44.2B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while DHANUKA.BO trades at ₹987.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas DHANUKA.BO's P/E ratio is 16.51. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to DHANUKA.BO's ROE of +0.17%. Regarding short-term risk, INDOUS.BO is more volatile compared to DHANUKA.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check DHANUKA.BO's competition here
Dhanuka Agritech Limited (NSE: DHANUKA.NS)
INDOUS.BO vs DHANUKA.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, DHANUKA.NS has a market cap of 43.9B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while DHANUKA.NS trades at ₹985.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas DHANUKA.NS's P/E ratio is 16.53. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to DHANUKA.NS's ROE of +0.17%. Regarding short-term risk, INDOUS.BO is more volatile compared to DHANUKA.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check DHANUKA.NS's competition here
NACL Industries Limited (NSE: NACLIND.NS)
INDOUS.BO vs NACLIND.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, NACLIND.NS has a market cap of 42.6B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while NACLIND.NS trades at ₹177.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas NACLIND.NS's P/E ratio is -62.74. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to NACLIND.NS's ROE of +0.02%. Regarding short-term risk, INDOUS.BO is less volatile compared to NACLIND.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check NACLIND.NS's competition here
NACL Industries Limited (BSE: NACLIND.BO)
INDOUS.BO vs NACLIND.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, NACLIND.BO has a market cap of 42.3B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while NACLIND.BO trades at ₹177.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas NACLIND.BO's P/E ratio is 677.98. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to NACLIND.BO's ROE of +0.02%. Regarding short-term risk, INDOUS.BO is less volatile compared to NACLIND.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check NACLIND.BO's competition here
Rallis India Limited (BSE: RALLIS.BO)
INDOUS.BO vs RALLIS.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, RALLIS.BO has a market cap of 41.6B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while RALLIS.BO trades at ₹213.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas RALLIS.BO's P/E ratio is 20.36. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to RALLIS.BO's ROE of +0.10%. Regarding short-term risk, INDOUS.BO is more volatile compared to RALLIS.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check RALLIS.BO's competition here
Rallis India Limited (NSE: RALLIS.NS)
INDOUS.BO vs RALLIS.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, RALLIS.NS has a market cap of 41.4B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while RALLIS.NS trades at ₹213.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas RALLIS.NS's P/E ratio is 20.38. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to RALLIS.NS's ROE of +0.10%. Regarding short-term risk, INDOUS.BO is more volatile compared to RALLIS.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check RALLIS.NS's competition here
Kaveri Seed Company Limited (NSE: KSCL.NS)
INDOUS.BO vs KSCL.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, KSCL.NS has a market cap of 40.5B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while KSCL.NS trades at ₹785.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas KSCL.NS's P/E ratio is 16.05. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to KSCL.NS's ROE of +0.15%. Regarding short-term risk, INDOUS.BO is more volatile compared to KSCL.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check KSCL.NS's competition here
Kaveri Seed Company Limited (BSE: KSCL.BO)
INDOUS.BO vs KSCL.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, KSCL.BO has a market cap of 40.5B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while KSCL.BO trades at ₹786.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas KSCL.BO's P/E ratio is 16.06. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to KSCL.BO's ROE of +0.15%. Regarding short-term risk, INDOUS.BO is more volatile compared to KSCL.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check KSCL.BO's competition here
Bhagiradha Chemicals & Industries Limited (BSE: BHAGCHEM.BO)
INDOUS.BO vs BHAGCHEM.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, BHAGCHEM.BO has a market cap of 37.3B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while BHAGCHEM.BO trades at ₹285.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas BHAGCHEM.BO's P/E ratio is 203.94. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to BHAGCHEM.BO's ROE of +0.04%. Regarding short-term risk, INDOUS.BO is less volatile compared to BHAGCHEM.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check BHAGCHEM.BO's competition here
Bhagiradha Chemicals & Industries Limited (NSE: BHAGCHEM.NS)
INDOUS.BO vs BHAGCHEM.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, BHAGCHEM.NS has a market cap of 37.2B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while BHAGCHEM.NS trades at ₹286.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas BHAGCHEM.NS's P/E ratio is 203.69. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to BHAGCHEM.NS's ROE of +0.04%. Regarding short-term risk, INDOUS.BO is less volatile compared to BHAGCHEM.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check BHAGCHEM.NS's competition here
Mangalore Chemicals & Fertilizers Limited (NSE: MANGCHEFER.NS)
INDOUS.BO vs MANGCHEFER.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, MANGCHEFER.NS has a market cap of 36.6B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while MANGCHEFER.NS trades at ₹308.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas MANGCHEFER.NS's P/E ratio is 22.67. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to MANGCHEFER.NS's ROE of +0.07%. Regarding short-term risk, INDOUS.BO is less volatile compared to MANGCHEFER.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check MANGCHEFER.NS's competition here
Mangalore Chemicals & Fertilizers Limited (BSE: MANGCHEFER.BO)
INDOUS.BO vs MANGCHEFER.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, MANGCHEFER.BO has a market cap of 36.6B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while MANGCHEFER.BO trades at ₹308.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas MANGCHEFER.BO's P/E ratio is 22.63. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to MANGCHEFER.BO's ROE of +0.07%. Regarding short-term risk, INDOUS.BO is less volatile compared to MANGCHEFER.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check MANGCHEFER.BO's competition here
National Fertilizers Limited (NSE: NFL.NS)
INDOUS.BO vs NFL.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, NFL.NS has a market cap of 35.5B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while NFL.NS trades at ₹71.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas NFL.NS's P/E ratio is 16.76. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to NFL.NS's ROE of +0.14%. Regarding short-term risk, INDOUS.BO is more volatile compared to NFL.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check NFL.NS's competition here
National Fertilizers Limited (BSE: NFL.BO)
INDOUS.BO vs NFL.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, NFL.BO has a market cap of 35.5B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while NFL.BO trades at ₹71.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas NFL.BO's P/E ratio is 16.77. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to NFL.BO's ROE of +0.14%. Regarding short-term risk, INDOUS.BO is more volatile compared to NFL.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check NFL.BO's competition here
BN Holdings Ltd. (BSE: BNHOLDINGS.BO)
INDOUS.BO vs BNHOLDINGS.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, BNHOLDINGS.BO has a market cap of 34.8B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while BNHOLDINGS.BO trades at ₹355.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas BNHOLDINGS.BO's P/E ratio is 26.71. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to BNHOLDINGS.BO's ROE of +0.10%. Regarding short-term risk, INDOUS.BO is less volatile compared to BNHOLDINGS.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check BNHOLDINGS.BO's competition here
Jubilant Agri and Consumer Products Ltd. (NSE: JUBLCPL.NS)
INDOUS.BO vs JUBLCPL.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, JUBLCPL.NS has a market cap of 32.4B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while JUBLCPL.NS trades at ₹2,141.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas JUBLCPL.NS's P/E ratio is 25.69. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to JUBLCPL.NS's ROE of +0.32%. Regarding short-term risk, INDOUS.BO is less volatile compared to JUBLCPL.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check JUBLCPL.NS's competition here
Jubilant Agri and Consumer Products Limited (BSE: JUBLCPL.BO)
INDOUS.BO vs JUBLCPL.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, JUBLCPL.BO has a market cap of 32.2B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while JUBLCPL.BO trades at ₹2,175.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas JUBLCPL.BO's P/E ratio is 95.70. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to JUBLCPL.BO's ROE of +0.30%. Regarding short-term risk, INDOUS.BO is less volatile compared to JUBLCPL.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check JUBLCPL.BO's competition here
Insecticides (India) Limited (BSE: INSECTICID.BO)
INDOUS.BO vs INSECTICID.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, INSECTICID.BO has a market cap of 16.9B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while INSECTICID.BO trades at ₹580.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas INSECTICID.BO's P/E ratio is 13.21. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to INSECTICID.BO's ROE of +0.10%. Regarding short-term risk, INDOUS.BO is more volatile compared to INSECTICID.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check INSECTICID.BO's competition here
Insecticides (India) Limited (NSE: INSECTICID.NS)
INDOUS.BO vs INSECTICID.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, INSECTICID.NS has a market cap of 16.9B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while INSECTICID.NS trades at ₹579.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas INSECTICID.NS's P/E ratio is 13.19. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to INSECTICID.NS's ROE of +0.10%. Regarding short-term risk, INDOUS.BO is more volatile compared to INSECTICID.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check INSECTICID.NS's competition here
India Pesticides Limited (NSE: IPL.NS)
INDOUS.BO vs IPL.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, IPL.NS has a market cap of 16.1B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while IPL.NS trades at ₹140.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas IPL.NS's P/E ratio is 14.95. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to IPL.NS's ROE of +0.11%. Regarding short-term risk, INDOUS.BO is more volatile compared to IPL.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check IPL.NS's competition here
India Pesticides Limited (BSE: IPL.BO)
INDOUS.BO vs IPL.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, IPL.BO has a market cap of 16B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while IPL.BO trades at ₹140.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas IPL.BO's P/E ratio is 14.95. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to IPL.BO's ROE of +0.11%. Regarding short-term risk, INDOUS.BO is more volatile compared to IPL.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check IPL.BO's competition here
Meghmani Organics Limited (BSE: MOL.BO)
INDOUS.BO vs MOL.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, MOL.BO has a market cap of 16B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while MOL.BO trades at ₹61.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas MOL.BO's P/E ratio is 30.51. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to MOL.BO's ROE of +0.04%. Regarding short-term risk, INDOUS.BO is less volatile compared to MOL.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check MOL.BO's competition here
Meghmani Organics Limited (NSE: MOL.NS)
INDOUS.BO vs MOL.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, MOL.NS has a market cap of 15.9B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while MOL.NS trades at ₹61.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas MOL.NS's P/E ratio is 55.32. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to MOL.NS's ROE of +0.04%. Regarding short-term risk, INDOUS.BO is less volatile compared to MOL.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check MOL.NS's competition here
Southern Petrochemical Industries Corporation Limited (NSE: SPIC.NS)
INDOUS.BO vs SPIC.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, SPIC.NS has a market cap of 14.4B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while SPIC.NS trades at ₹70.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas SPIC.NS's P/E ratio is 6.78. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to SPIC.NS's ROE of +0.16%. Regarding short-term risk, INDOUS.BO is more volatile compared to SPIC.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check SPIC.NS's competition here
Southern Petrochemical Industries Corporation Limited (BSE: SPIC.BO)
INDOUS.BO vs SPIC.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, SPIC.BO has a market cap of 14.3B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while SPIC.BO trades at ₹70.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas SPIC.BO's P/E ratio is 6.78. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to SPIC.BO's ROE of +0.16%. Regarding short-term risk, INDOUS.BO is more volatile compared to SPIC.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check SPIC.BO's competition here
Punjab Chemicals & Crop Protection Ltd. (BSE: PUNJABCHEM.BO)
INDOUS.BO vs PUNJABCHEM.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, PUNJABCHEM.BO has a market cap of 13.4B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while PUNJABCHEM.BO trades at ₹1,122.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas PUNJABCHEM.BO's P/E ratio is 20.99. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to PUNJABCHEM.BO's ROE of +0.16%. Regarding short-term risk, INDOUS.BO is less volatile compared to PUNJABCHEM.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check PUNJABCHEM.BO's competition here
Punjab Chemicals & Crop Protection Limited (NSE: PUNJABCHEM.NS)
INDOUS.BO vs PUNJABCHEM.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, PUNJABCHEM.NS has a market cap of 13.4B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while PUNJABCHEM.NS trades at ₹1,119.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas PUNJABCHEM.NS's P/E ratio is 20.90. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to PUNJABCHEM.NS's ROE of +0.16%. Regarding short-term risk, INDOUS.BO is less volatile compared to PUNJABCHEM.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check PUNJABCHEM.NS's competition here
Astec LifeSciences Limited (BSE: ASTEC.BO)
INDOUS.BO vs ASTEC.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, ASTEC.BO has a market cap of 13.3B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while ASTEC.BO trades at ₹592.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas ASTEC.BO's P/E ratio is -19.97. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to ASTEC.BO's ROE of -0.17%. Regarding short-term risk, INDOUS.BO is more volatile compared to ASTEC.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check ASTEC.BO's competition here
Astec LifeSciences Limited (NSE: ASTEC.NS)
INDOUS.BO vs ASTEC.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, ASTEC.NS has a market cap of 13.3B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while ASTEC.NS trades at ₹593.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas ASTEC.NS's P/E ratio is -19.84. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to ASTEC.NS's ROE of -0.17%. Regarding short-term risk, INDOUS.BO is less volatile compared to ASTEC.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check ASTEC.NS's competition here
Madras Fertilizers Limited (BSE: MADRASFERT.BO)
INDOUS.BO vs MADRASFERT.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, MADRASFERT.BO has a market cap of 11.3B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while MADRASFERT.BO trades at ₹69.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas MADRASFERT.BO's P/E ratio is 14.01. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to MADRASFERT.BO's ROE of +2.60%. Regarding short-term risk, INDOUS.BO is less volatile compared to MADRASFERT.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check MADRASFERT.BO's competition here
Madras Fertilizers Limited (NSE: MADRASFERT.NS)
INDOUS.BO vs MADRASFERT.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, MADRASFERT.NS has a market cap of 11.2B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while MADRASFERT.NS trades at ₹69.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas MADRASFERT.NS's P/E ratio is 13.96. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to MADRASFERT.NS's ROE of +2.60%. Regarding short-term risk, INDOUS.BO is less volatile compared to MADRASFERT.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check MADRASFERT.NS's competition here
Bharat Rasayan Limited (NSE: BHARATRAS.NS)
INDOUS.BO vs BHARATRAS.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, BHARATRAS.NS has a market cap of 10.6B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while BHARATRAS.NS trades at ₹1,278.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas BHARATRAS.NS's P/E ratio is 7.88. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to BHARATRAS.NS's ROE of +0.12%. Regarding short-term risk, INDOUS.BO is more volatile compared to BHARATRAS.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check BHARATRAS.NS's competition here
Bharat Rasayan Limited (BSE: BHARATRAS.BO)
INDOUS.BO vs BHARATRAS.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, BHARATRAS.BO has a market cap of 10.6B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while BHARATRAS.BO trades at ₹1,274.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas BHARATRAS.BO's P/E ratio is 9.91. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to BHARATRAS.BO's ROE of +0.12%. Regarding short-term risk, INDOUS.BO is more volatile compared to BHARATRAS.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check BHARATRAS.BO's competition here
Zuari Agro Chemicals Limited (BSE: ZUARI.BO)
INDOUS.BO vs ZUARI.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, ZUARI.BO has a market cap of 9.8B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while ZUARI.BO trades at ₹234.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas ZUARI.BO's P/E ratio is 1.06. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to ZUARI.BO's ROE of +0.39%. Regarding short-term risk, INDOUS.BO is more volatile compared to ZUARI.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check ZUARI.BO's competition here
Zuari Agro Chemicals Limited (NSE: ZUARI.NS)
INDOUS.BO vs ZUARI.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, ZUARI.NS has a market cap of 9.8B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while ZUARI.NS trades at ₹234.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas ZUARI.NS's P/E ratio is 1.06. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to ZUARI.NS's ROE of +0.39%. Regarding short-term risk, INDOUS.BO is more volatile compared to ZUARI.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check ZUARI.NS's competition here
Bombay Super Hybrid Seeds Limited (NSE: BSHSL.NS)
INDOUS.BO vs BSHSL.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, BSHSL.NS has a market cap of 9.3B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while BSHSL.NS trades at ₹89.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas BSHSL.NS's P/E ratio is 34.47. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to BSHSL.NS's ROE of +0.23%. Regarding short-term risk, INDOUS.BO is less volatile compared to BSHSL.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check BSHSL.NS's competition here
Dharmaj Crop Guard Limited (NSE: DHARMAJ.NS)
INDOUS.BO vs DHARMAJ.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, DHARMAJ.NS has a market cap of 9.2B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while DHARMAJ.NS trades at ₹269.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas DHARMAJ.NS's P/E ratio is 55.64. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to DHARMAJ.NS's ROE of +0.13%. Regarding short-term risk, INDOUS.BO is more volatile compared to DHARMAJ.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check DHARMAJ.NS's competition here
Dharmaj Crop Guard Limited (BSE: DHARMAJ.BO)
INDOUS.BO vs DHARMAJ.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, DHARMAJ.BO has a market cap of 9.1B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while DHARMAJ.BO trades at ₹271.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas DHARMAJ.BO's P/E ratio is 155.98. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to DHARMAJ.BO's ROE of +0.13%. Regarding short-term risk, INDOUS.BO is less volatile compared to DHARMAJ.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check DHARMAJ.BO's competition here
Heranba Industries Limited (BSE: HERANBA.BO)
INDOUS.BO vs HERANBA.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, HERANBA.BO has a market cap of 7B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while HERANBA.BO trades at ₹174.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas HERANBA.BO's P/E ratio is -9.29. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to HERANBA.BO's ROE of -0.09%. Regarding short-term risk, INDOUS.BO is more volatile compared to HERANBA.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check HERANBA.BO's competition here
Heranba Industries Limited (NSE: HERANBA.NS)
INDOUS.BO vs HERANBA.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, HERANBA.NS has a market cap of 7B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while HERANBA.NS trades at ₹174.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas HERANBA.NS's P/E ratio is -11.61. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to HERANBA.NS's ROE of -0.09%. Regarding short-term risk, INDOUS.BO is more volatile compared to HERANBA.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check HERANBA.NS's competition here
Best Agrolife Limited (NSE: BESTAGRO.NS)
INDOUS.BO vs BESTAGRO.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, BESTAGRO.NS has a market cap of 6.3B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while BESTAGRO.NS trades at ₹17.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas BESTAGRO.NS's P/E ratio is 21.04. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to BESTAGRO.NS's ROE of +0.04%. Regarding short-term risk, INDOUS.BO is more volatile compared to BESTAGRO.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check BESTAGRO.NS's competition here
Best Agrolife Limited (BSE: BESTAGRO.BO)
INDOUS.BO vs BESTAGRO.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, BESTAGRO.BO has a market cap of 6.2B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while BESTAGRO.BO trades at ₹17.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas BESTAGRO.BO's P/E ratio is 21.02. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to BESTAGRO.BO's ROE of +0.04%. Regarding short-term risk, INDOUS.BO is more volatile compared to BESTAGRO.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check BESTAGRO.BO's competition here
Aries Agro Limited (BSE: ARIES.BO)
INDOUS.BO vs ARIES.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, ARIES.BO has a market cap of 5.8B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while ARIES.BO trades at ₹503.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas ARIES.BO's P/E ratio is 13.50. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to ARIES.BO's ROE of +0.15%. Regarding short-term risk, INDOUS.BO is less volatile compared to ARIES.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check ARIES.BO's competition here
Aries Agro Limited (NSE: ARIES.NS)
INDOUS.BO vs ARIES.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, ARIES.NS has a market cap of 5.8B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while ARIES.NS trades at ₹503.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas ARIES.NS's P/E ratio is 13.55. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to ARIES.NS's ROE of +0.15%. Regarding short-term risk, INDOUS.BO is less volatile compared to ARIES.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check ARIES.NS's competition here
Khaitan Chemicals and Fertilizers Limited (BSE: KHAICHEM.BO)
INDOUS.BO vs KHAICHEM.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, KHAICHEM.BO has a market cap of 5.5B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while KHAICHEM.BO trades at ₹57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas KHAICHEM.BO's P/E ratio is 8.56. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to KHAICHEM.BO's ROE of +0.19%. Regarding short-term risk, INDOUS.BO is more volatile compared to KHAICHEM.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check KHAICHEM.BO's competition here
Khaitan Chemicals and Fertilizers Limited (NSE: KHAICHEM.NS)
INDOUS.BO vs KHAICHEM.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, KHAICHEM.NS has a market cap of 5.5B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while KHAICHEM.NS trades at ₹56.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas KHAICHEM.NS's P/E ratio is 8.52. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to KHAICHEM.NS's ROE of +0.19%. Regarding short-term risk, INDOUS.BO is more volatile compared to KHAICHEM.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check KHAICHEM.NS's competition here
Indogulf Cropsciences Ltd. (NSE: IGCL.NS)
INDOUS.BO vs IGCL.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, IGCL.NS has a market cap of 4.6B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while IGCL.NS trades at ₹72.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas IGCL.NS's P/E ratio is 10.77. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to IGCL.NS's ROE of +0.10%. Regarding short-term risk, INDOUS.BO is more volatile compared to IGCL.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check IGCL.NS's competition here
Rama Phosphates Limited (BSE: RAMAPHO.BO)
INDOUS.BO vs RAMAPHO.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, RAMAPHO.BO has a market cap of 4.5B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while RAMAPHO.BO trades at ₹127.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas RAMAPHO.BO's P/E ratio is 8.37. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to RAMAPHO.BO's ROE of +0.13%. Regarding short-term risk, INDOUS.BO is less volatile compared to RAMAPHO.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check RAMAPHO.BO's competition here
Shivalik Rasayan Limited (NSE: SHIVALIK.NS)
INDOUS.BO vs SHIVALIK.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, SHIVALIK.NS has a market cap of 4.4B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while SHIVALIK.NS trades at ₹294.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas SHIVALIK.NS's P/E ratio is 33.29. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to SHIVALIK.NS's ROE of +0.02%. Regarding short-term risk, INDOUS.BO is less volatile compared to SHIVALIK.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check SHIVALIK.NS's competition here
Rama Phosphates Limited (NSE: RAMAPHO.NS)
INDOUS.BO vs RAMAPHO.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, RAMAPHO.NS has a market cap of 4.4B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while RAMAPHO.NS trades at ₹128.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas RAMAPHO.NS's P/E ratio is 8.39. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to RAMAPHO.NS's ROE of +0.13%. Regarding short-term risk, INDOUS.BO is less volatile compared to RAMAPHO.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check RAMAPHO.NS's competition here
Shivalik Rasayan Limited (BSE: SHIVALIK.BO)
INDOUS.BO vs SHIVALIK.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, SHIVALIK.BO has a market cap of 4.2B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while SHIVALIK.BO trades at ₹293.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas SHIVALIK.BO's P/E ratio is 33.15. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to SHIVALIK.BO's ROE of +0.02%. Regarding short-term risk, INDOUS.BO is less volatile compared to SHIVALIK.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check SHIVALIK.BO's competition here
Nath Bio-Genes (India) Limited (NSE: NATHBIOGEN.NS)
INDOUS.BO vs NATHBIOGEN.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, NATHBIOGEN.NS has a market cap of 2.9B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while NATHBIOGEN.NS trades at ₹152.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas NATHBIOGEN.NS's P/E ratio is 7.67. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to NATHBIOGEN.NS's ROE of +0.06%. Regarding short-term risk, INDOUS.BO is more volatile compared to NATHBIOGEN.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check NATHBIOGEN.NS's competition here
Nath Bio-Genes (India) Limited (BSE: NATHBIOGEN.BO)
INDOUS.BO vs NATHBIOGEN.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, NATHBIOGEN.BO has a market cap of 2.9B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while NATHBIOGEN.BO trades at ₹153.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas NATHBIOGEN.BO's P/E ratio is 7.66. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to NATHBIOGEN.BO's ROE of +0.06%. Regarding short-term risk, INDOUS.BO is more volatile compared to NATHBIOGEN.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check NATHBIOGEN.BO's competition here
Tierra Agrotech Limited (BSE: TIERRA.BO)
INDOUS.BO vs TIERRA.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, TIERRA.BO has a market cap of 2.8B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while TIERRA.BO trades at ₹43.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas TIERRA.BO's P/E ratio is -54.55. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to TIERRA.BO's ROE of -0.07%. Regarding short-term risk, INDOUS.BO is less volatile compared to TIERRA.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check TIERRA.BO's competition here
Nova Agritech Limited (NSE: NOVAAGRI.NS)
INDOUS.BO vs NOVAAGRI.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, NOVAAGRI.NS has a market cap of 2.2B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while NOVAAGRI.NS trades at ₹24.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas NOVAAGRI.NS's P/E ratio is 17.41. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to NOVAAGRI.NS's ROE of +0.06%. Regarding short-term risk, INDOUS.BO is less volatile compared to NOVAAGRI.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check NOVAAGRI.NS's competition here
Indo Us Bio-Tech Ltd. (NSE: INDOUS.NS)
INDOUS.BO vs INDOUS.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, INDOUS.NS has a market cap of 1.6B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while INDOUS.NS trades at ₹80.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas INDOUS.NS's P/E ratio is 12.54. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to INDOUS.NS's ROE of +0.13%. Regarding short-term risk, INDOUS.BO is less volatile compared to INDOUS.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check INDOUS.NS's competition here
Mangalam Seeds Limited (BSE: MSL.BO)
INDOUS.BO vs MSL.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, MSL.BO has a market cap of 1.6B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while MSL.BO trades at ₹149.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas MSL.BO's P/E ratio is 19.81. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to MSL.BO's ROE of +0.10%. Regarding short-term risk, INDOUS.BO is more volatile compared to MSL.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check MSL.BO's competition here
Crop Life Science Ltd. (NSE: CLSL.NS)
INDOUS.BO vs CLSL.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, CLSL.NS has a market cap of 1.5B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while CLSL.NS trades at ₹90.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas CLSL.NS's P/E ratio is 22.20. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to CLSL.NS's ROE of N/A. Regarding short-term risk, INDOUS.BO is less volatile compared to CLSL.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check CLSL.NS's competition here
Sir Shadi Lal Enterprises Limited (BSE: SSLEL.BO)
INDOUS.BO vs SSLEL.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, SSLEL.BO has a market cap of 1.4B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while SSLEL.BO trades at ₹263.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas SSLEL.BO's P/E ratio is -5.77. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to SSLEL.BO's ROE of +0.11%. Regarding short-term risk, INDOUS.BO is less volatile compared to SSLEL.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check SSLEL.BO's competition here
Mayank Cattle Food Limited (BSE: MCFL.BO)
INDOUS.BO vs MCFL.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, MCFL.BO has a market cap of 1.3B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while MCFL.BO trades at ₹122.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas MCFL.BO's P/E ratio is 12.20. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to MCFL.BO's ROE of +0.17%. Regarding short-term risk, INDOUS.BO is more volatile compared to MCFL.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check MCFL.BO's competition here
Nagarjuna Fertilizers and Chemicals Limited (NSE: NAGAFERT.NS)
INDOUS.BO vs NAGAFERT.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, NAGAFERT.NS has a market cap of 1.3B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while NAGAFERT.NS trades at ₹2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas NAGAFERT.NS's P/E ratio is -8.46. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to NAGAFERT.NS's ROE of +0.02%. Regarding short-term risk, INDOUS.BO is more volatile compared to NAGAFERT.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check NAGAFERT.NS's competition here
Nagarjuna Fertilizers And Chem (BSE: NAGAFERT.BO)
INDOUS.BO vs NAGAFERT.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, NAGAFERT.BO has a market cap of 1.3B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while NAGAFERT.BO trades at ₹2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas NAGAFERT.BO's P/E ratio is -4.64. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to NAGAFERT.BO's ROE of +0.02%. Regarding short-term risk, INDOUS.BO is more volatile compared to NAGAFERT.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check NAGAFERT.BO's competition here
Bharat Agri Fert & Realty Ltd. (BSE: BHARATAGRI.BO)
INDOUS.BO vs BHARATAGRI.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, BHARATAGRI.BO has a market cap of 1.3B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while BHARATAGRI.BO trades at ₹23.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas BHARATAGRI.BO's P/E ratio is -31.36. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to BHARATAGRI.BO's ROE of -0.14%. Regarding short-term risk, INDOUS.BO is less volatile compared to BHARATAGRI.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check BHARATAGRI.BO's competition here
B & A Limited (BSE: BNALTD.BO)
INDOUS.BO vs BNALTD.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, BNALTD.BO has a market cap of 1.2B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while BNALTD.BO trades at ₹404.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas BNALTD.BO's P/E ratio is -8.72. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to BNALTD.BO's ROE of +0.00%. Regarding short-term risk, INDOUS.BO is more volatile compared to BNALTD.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check BNALTD.BO's competition here
Basant Agro Tech (India) Limited (BSE: BASANTGL.BO)
INDOUS.BO vs BASANTGL.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, BASANTGL.BO has a market cap of 1.1B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while BASANTGL.BO trades at ₹11.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas BASANTGL.BO's P/E ratio is 76.88. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to BASANTGL.BO's ROE of +0.04%. Regarding short-term risk, INDOUS.BO is less volatile compared to BASANTGL.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check BASANTGL.BO's competition here
ShreeOswal Seeds and Chemicals Limited (NSE: OSWALSEEDS.NS)
INDOUS.BO vs OSWALSEEDS.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, OSWALSEEDS.NS has a market cap of 1.1B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while OSWALSEEDS.NS trades at ₹12.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas OSWALSEEDS.NS's P/E ratio is 15.23. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to OSWALSEEDS.NS's ROE of +0.26%. Regarding short-term risk, INDOUS.BO is less volatile compared to OSWALSEEDS.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check OSWALSEEDS.NS's competition here
Sikko Industries Limited (NSE: SIKKO.NS)
INDOUS.BO vs SIKKO.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, SIKKO.NS has a market cap of 1.1B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while SIKKO.NS trades at ₹5.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas SIKKO.NS's P/E ratio is 4.44. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to SIKKO.NS's ROE of +0.07%. Regarding short-term risk, INDOUS.BO is less volatile compared to SIKKO.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check SIKKO.NS's competition here
Narmada Agrobase Limited (NSE: NARMADA.NS)
INDOUS.BO vs NARMADA.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, NARMADA.NS has a market cap of 1.1B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while NARMADA.NS trades at ₹13.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas NARMADA.NS's P/E ratio is 27.18. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to NARMADA.NS's ROE of +0.06%. Regarding short-term risk, INDOUS.BO is less volatile compared to NARMADA.NS. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check NARMADA.NS's competition here
Narmada Agrobase Limited (BSE: NARMADA.BO)
INDOUS.BO vs NARMADA.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, NARMADA.BO has a market cap of 1.1B. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while NARMADA.BO trades at ₹13.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas NARMADA.BO's P/E ratio is 27.47. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to NARMADA.BO's ROE of +0.06%. Regarding short-term risk, INDOUS.BO is less volatile compared to NARMADA.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check NARMADA.BO's competition here
Upsurge Seeds of Agriculture Ltd. (NSE: USASEEDS.NS)
INDOUS.BO vs USASEEDS.NS Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, USASEEDS.NS has a market cap of 929.4M. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while USASEEDS.NS trades at ₹96.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas USASEEDS.NS's P/E ratio is 15.13. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to USASEEDS.NS's ROE of N/A. Regarding short-term risk, INDOUS.BO is more volatile compared to USASEEDS.NS. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check USASEEDS.NS's competition here
Indra Industries Limited (BSE: INDRAIND.BO)
INDOUS.BO vs INDRAIND.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, INDRAIND.BO has a market cap of 907.3M. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while INDRAIND.BO trades at ₹16.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas INDRAIND.BO's P/E ratio is 74.91. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to INDRAIND.BO's ROE of -0.29%. Regarding short-term risk, INDOUS.BO is more volatile compared to INDRAIND.BO. This indicates higher risk in terms of short-term price fluctuations for INDOUS.BO.Check INDRAIND.BO's competition here
Gayatri Sugars Limited (BSE: GAYATRI.BO)
INDOUS.BO vs GAYATRI.BO Comparison August 2026
Indo US Bio-Tech Limited (BSE: INDOUS.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDOUS.BO stands at 1.7B. In comparison, GAYATRI.BO has a market cap of 671.7M. Regarding current trading prices, INDOUS.BO is priced at ₹81.36 on the BSE, while GAYATRI.BO trades at ₹8.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDOUS.BO currently has a P/E ratio of 12.79, whereas GAYATRI.BO's P/E ratio is 56.50. In terms of profitability, INDOUS.BO's ROE is +0.13%, compared to GAYATRI.BO's ROE of -0.02%. Regarding short-term risk, INDOUS.BO is less volatile compared to GAYATRI.BO. This indicates lower risk in terms of short-term price fluctuations for INDOUS.BO.Check GAYATRI.BO's competition here